Design Therapeutics
DSGN
#7170
Rank
NZ$1.05 B
Marketcap
NZ$16.49
Share price
-3.22%
Change (1 day)
10.88%
Change (1 year)

Earnings for Design Therapeutics (DSGN)

Earnings in 2026 (TTM): -NZ$0.15 Billion

According to Design Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.15 Billion a decrease over its 2024 earnings that were of -NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Design Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.15 Billion-0.78%
2025 -NZ$0.15 Billion27.39%
2024 -NZ$0.12 Billion-20.22%
2023 -NZ$0.15 Billion15.68%
2022 -NZ$0.13 Billion88.64%
2021 -NZ$65.5 Million330.14%
2020 -NZ$15.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion 89.76%๐Ÿ‡บ๐Ÿ‡ธ USA